Chagas ECHO

Chagas disease is an infection with the parasite Trypanosoma cruzi (T. cruzi) and is endemic throughout the Americas. Often called a “silent killer”, this chronic disease can go undetected for years and even decades, resulting in irreversible damage or death. Unfortunately, less than 1% of known Chagas disease cases in the US have been diagnosed or received appropriate treatment.

The Chagas ECHO aims to address this critical treatment gap by convening a national group of Chagas disease experts to share knowledge about screening, surveillance, and treatment. Sessions run January through April, 2020. Register here.

Learn more about Chagas Disease

View the Chagas ECHO Program Flyer

Become an ECHO Partner Site

Anyone can attend an ECHO session, but before providers present a case for discussion we ask them to complete a few basic steps:

Become an ECHO partner

Conditions of Collaboration

COVID-19 Telemedicine Implementation ECHO

In response to the necessity of a number of clinics and providers having to implement telemedicine at short notice, the UT San Antonio ECHO Program, in partnership with the UT System Virtual Health Network is launching a COVID-19 Telemedicine Implementation ECHO. Each week, a team of experts will deliver a brief presentation on key considerations and strategies for launching a telemedicine program, including evolving regulations, technology, and clinical considerations. Session slides and recordings will be made available after the session on our resources page.

Following the didactic, there will be a case presentation from a clinic who is launching or expanding telemedicine delivery of care during the COVID-19 emergency. Finally, we will have a robust interactive discussion period.

This new ECHO will launch 12-1:15pm CST March 30th and will recur every week via Zoom videoconferencing. Participation is free and all are welcome. Register here.

View COVID-19 Telemedicine Implementation ECHO Flyer

Learn more about COVID-19 Telemedicine Implementation ECHO


Hepatitis C Virus ECHO

As the most common blood-borne infection and a leading cause of liver disease, failure, and cancer, hepatitis C virus (HCV) poses a major threat to the health of our communities. To address this, we are establishing an HCV ECHO to educate practitioners about the disease and provide evidence-based, interdisciplinary guidance for management and treatment using highly effective, direct-acting antivirals. Our team is made up of experts in HCV care delivery, including a hepatologist, a community-based pharmacist, an infectious diseases specialist, and a community health worker with more than 6 years in supporting uninsured patients who are diagnosed chronic HCV (in rural and urban settings).

Our expert panel includes: 

  • Hopethe Hubbard MD, Hepatologist
  • Waridibo Allison MD, PhD, Infectious Disease Specialist
  • Margaret Adjei PharmD, Pharmacist
  • Ludivina Hernandez CHW, Community Health Worker

This new ECHO will launch in March, 2020. Continuing medical education (CME) is available for free to attendees. Register here.

View HCV ECHO Program Flyer

ST-AHEC Community Health Worker opioid use disorder training

The ST-AHEC has launched an ECHO to provide opioid use disorder training for community health workers (CHWs).

The goal of this ECHO is to improve workforce training in opioid addiction, harm reduction, and recovery services that utilize CHW services throughout South Texas.

For more information, visit the South Texas AHEC Program Page


UT Health San Antonio began its ECHO journey with its inaugural HIV/HCV ECHO as a component of the larger TAKCLE HIV/HCV program, a multifaceted program to cure HCV in people living with HIV in South Texas.

For more information, visit the TACKLE HIV/HCV Program Site

TxMOUD (Medication for Opioid Use Disorder) Community of Practice ECHO

TxMOUD Community of Practice ECHO has three main goals:

  • Help providers learn more about buprenorphine treatment for OUD
  • Deliver information to providers on how to receive their DEA X-waiver to prescribe buprenorphine
  • Provide advice about starting buprenorphine treatment at their practice.

TxMOUD Community of Practice ECHO uses web-conferencing to share best practices through didactic presentation and case-based learning. These sessions offer the opportunity to connect with TxMOUD trainers and OUD treatment champions for advice about a variety of topics.

The Long School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Each session will be for 1.00 AMA PRA Category 1 CreditTM. MD’s and DO’s will receive a certificate of credit per the AMA (American Medical Association) requirements and all other attendees will receive a certificate of attendance.

To learn more and register for an ECHO session, visit TxMOUD

Previous ECHO Programs:

GetWaiveredTX Buprenorphine for OUD

The GetWaivered program has three main goals:

  • Promote awareness of buprenorphine treatment for opioid use disorder
  • Provide health care providers with the required training to provide this life-saving treatment
  • Assist trained clinicians to complete the DEA X-waiver process

GetWaivered TX launched an ECHO to establish a community of practice that supported providers through the training and waiver processes. These sessions offered the opportunity to connect with GetWaiveredTX trainers and OUD treatment champions for advice about a variety of topics. The ECHO series evolved into the Texas MOUD (Medication for Opioid Use Disorder) Community of Practice ECHO (See above).

Visit the GetWaivered TX Site